Passage Bio (NYSE:GFL)‘s stock had its “buy” rating reiterated by BMO Capital Markets in a research note issued to investors on Monday, AnalystRatings.com reports.
A number of other brokerages also recently issued reports on GFL. JPMorgan Chase & Co. initiated coverage on Passage Bio in a report on Monday, March 30th. They set an “overweight” rating and a $19.00 price target on the stock. Scotiabank initiated coverage on Passage Bio in a report on Monday, March 30th. They set an “outperform” rating and a $23.00 price target on the stock. National Bank Financial initiated coverage on Passage Bio in a report on Tuesday, April 14th. They set an “outperform” rating on the stock. Bank of America initiated coverage on Passage Bio in a report on Monday, March 30th. They set a “neutral” rating on the stock. Finally, Goldman Sachs Group assumed coverage on Passage Bio in a report on Monday, March 30th. They set a “neutral” rating on the stock. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $23.05.
Passage Bio stock opened at $18.77 on Monday. The business has a fifty day moving average of $18.40. Passage Bio has a 12 month low of $11.92 and a 12 month high of $20.97.
About Passage Bio
GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.
Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.